Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen vs PRP for Atrophic Vaginitis
NCT05118685Phase 1Unknown
- Sponsor
- Fayoum University
- Start
- Nov 2021
- Primary completion
- Aug 2023
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of autologous platelet rich gel in atrophic vaginitis (2 arms), sponsored by Fayoum University. Primary endpoints: Vaginal Health Index at 12 weeks, Vulvovaginal Atrophy Symptoms Visual Analog Scale at 12 weeks and 1 more. Status: unknown.
02
Drugs
autologous platelet rich gel
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on NCT05118685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05118685.